Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Teva
Cerilliant
Merck
Farmers Insurance
McKesson
Fuji
UBS
Cantor Fitzgerald

Generated: August 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,962,115

« Back to Dashboard

Summary for Patent: 4,962,115
Title: Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
Abstract:Novel N-(3-hydroxy-4-piperidinyl)benzamides and derivatives thereof, said compounds being useful as stimulators of the motility of the gastro-intestinal system.
Inventor(s): Van Daele; Georges (Turnhout, BE)
Assignee: Janssen Pharmaceutica N.V. (Beerse, BE)
Application Number:07/443,060
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Use;

Drugs Protected by US Patent 4,962,115

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 4,962,115

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Croatia P930478 ➤ Sign Up
European Patent Office 0076530 ➤ Sign Up SPC/GB93/037 United Kingdom ➤ Sign Up
Spain 8400405 ➤ Sign Up
Spain 542439 ➤ Sign Up
Spain 8603413 ➤ Sign Up
Finland 823348 ➤ Sign Up
Finland 78073 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Express Scripts
Cerilliant
Moodys
Federal Trade Commission
Queensland Health
McKinsey
QuintilesIMS
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.